WINNIPEG, Manitoba--(BUSINESS WIRE)--#Cubresa--Barrow Neurological Institute, the world’s largest neurological disease treatment and research institution, in conjunction with Arizona State University (ASU), have selected Cubresa’s BrainPET system to a
BURLINGTON, Ontario--(BUSINESS WIRE)--Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian biotechnology company revolutionizing drug delivery through innovation, is pleased to announce another significant addition to the
TORONTO--(BUSINESS WIRE)--Apollo Healthcare Corp. (TSX: AHC, OTCXQ: AHCCF) (“Apollo” or the “Company”) today announced that it has obtained a final order from the Ontario Superior Court of Justice (Commercial List) approving the previously announc
VICTORIA, British Columbia--(BUSINESS WIRE)--Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (the “Company”) today announced that members of the management team will participate in two upcoming virtual investor conferences. H.C. Wainwright Virtual BioCo
TORONTO--(BUSINESS WIRE)--Organic Potash Corporation (“OPC” or the “Corporation”) OPC is pleased to announce a significant event, with respect to its operations in West Africa. OPC through its subsidiary in West Africa, OPC Ivory Coast (OPCIC) In
LAVAL, Quebec--(BUSINESS WIRE)--#Altasciences--Altasciences, an integrated CRO/CDMO offering pharmaceutical and biotechnology companies a seamless solution to early-stage drug development from lead candidate selection to clinical proof of concept, announc
Nutrien launches global search for long-term CEO and names Ken Seitz as interim leader SASKATOON, Saskatchewan--(BUSINESS WIRE)--The Board of Directors of Nutrien Ltd. (TSX and NYSE: NTR), the world's largest provider of crop inputs and services, announc
TORONTO--(BUSINESS WIRE)--Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical technology company focused on the development and commercialization of innovative single access robotic-assisted surgery systems and technology, announced today that it compl
TORONTO--(BUSINESS WIRE)--$HUGE #FSDPharma--FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) (“FSD Pharma” or the “Company”), a life sciences holding company dedicated to building a portfolio of assets and biotech solutions, announced today
Company Celebrates Expansion in Virginia; Continues National Momentum of Cannabist Transformation Eight Additional Dispensaries Expected to Open in Virginia by End of 2022 – Bringing Total to 12 State-Wide NEW YORK--(BUSINESS WIRE)--Columbia Care Inc.
Sign up for one of BAM's newsletter to learn more about bioscience, happenings in Manitoba's bioeconomy, industry conferences, and BAM training events.